Mechanism of Action
MT-II activates melanocortin receptors, particularly MC1R in melanocytes (causing tanning) and MC4R in the hypothalamus (causing sexual arousal and appetite suppression). The tanning effect occurs without UV exposure, though UV light accelerates and deepens the tan produced. The sexual arousal effect is centrally mediated and pronounced.
Ester Profile
Synthetic peptide. No ester. Subcutaneous injection. Short active half-life but downstream effects on melanin production persist for days to weeks after dosing.
How It's Used in Fitness
Melanotan II is used in performance and physique settings primarily for the tanning effect — producing a deep tan that enhances the appearance of muscle definition and vascularity without sun exposure. It is particularly used before photoshoots, competitions, or simply for aesthetics. The appetite suppression it produces is also used by some individuals during cutting phases. The sexual side effects are considered a benefit by most users.
Stacking Context
Melanotan II is not stacked in the traditional pharmacological sense — it does not interact with androgen receptors or hormonal pathways that other performance compounds target. It is used independently and alongside whatever other protocol is in place, primarily for aesthetic purposes. Its timing relative to competitions or photoshoots determines the dosing schedule rather than any interaction with other compounds.
Medical Use
- Phase II trials for erectile dysfunction — not approved
- Phase II trials for female sexual dysfunction — not approved
- PT-141 (Bremelanotide) — related compound approved for female sexual dysfunction in USA
Side Effects
- Nausea — very common during loading phase
- Facial flushing
- Involuntary erections — spontaneous and sustained
- Mole changes and darkening
- Potential melanoma risk in individuals with atypical moles
- Fatigue and appetite suppression
- Injection site reactions
- Yawning — characteristic melanocortin side effect
What Actually Goes Wrong
Melanotan II causes nausea, facial flushing, and involuntary erections in most users during the loading phase. These side effects are dose-dependent and reduce with continued use. The more significant concern is the effect on existing moles and pigmented lesions. Melanocortin receptor activation has been associated with changes in pre-existing moles and has raised concerns about melanoma risk in individuals with existing atypical moles. Any individual with a personal or family history of melanoma or multiple atypical moles should not use this compound. The supply chain is entirely unregulated with significant quality variability.
Detection Window
WADA bans peptide hormones broadly. Specific MT-II detection methodology limited.
Melanotan II produces what it promises in terms of tanning and the other effects most users are aware of before starting. The mole and pigmentation concern is worth taking seriously, particularly for anyone with fair skin, multiple moles, or family history of skin cancer. A dermatological assessment of existing moles before use is a reasonable minimum precaution that most users skip entirely.